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ABSTRACT  
Aims/hypothesis: piRNAs are small non-coding RNAs that interact with PIWI proteins and guide 
them to silence transposable elements. They are abundantly expressed in germline cells and play 
key roles in spermatogenesis. There is mounting evidence indicating that piRNAs are also present 
in somatic cells where they may accomplish additional regulatory tasks. The aim of this study 
was to identify the piRNAs expressed in pancreatic islets and to determine whether they are 
involved in the control of beta-cell activities.  
Methods: piRNA profiling of rat pancreatic islets was performed by microarray. The functions of 
piRNAs was investigated by silencing the two main Piwi genes or by modulating the level of 
selected piRNAs in islet cells. 
Results: We detected about 18’000 piRNAs in rat pancreatic islets, many of which were 
differentially expressed throughout islet postnatal development. Moreover, we identified changes 
in the level of several piRNAs in the islets of Goto-Kakizaki rats, a well-established model of 
Type 2 diabetes. Silencing of Piwil2 or Piwil4 genes in adult rat islets caused a reduction in the 
level of several piRNAs and resulted in defective insulin secretion and in increased resistance of 
the cells to cytokine-induced cell death. Furthermore, overexpression in the islets of control 
animals of two piRNAs that are up-regulated in diabetic rats, led to a selective defect in glucose-
induced insulin release. 
Conclusions/interpretation:  Our results provide evidence for a role of PIWI proteins and their 
associated piRNAs in the control of beta-cell functions and suggest a possible involvement in the 
development of Type 2 diabetes. 
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Data have been deposited in Gene Expression Omnibus repository under the accession number 
GSE93792 
The reviewers can access to the data via the following link:  
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ojklueugdzehpkv&acc=GSE93792 
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Abbreviations 
PIWI : P-element induced Wimpy testis 
Piwil : Piwi-like gene 
piRNA: PIWI-interacting RNA 
qRT-PCR: Quantitative Reverse Transcription real-time PCR 
GK: Goto-Kakizaki  
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INTRODUCTION 
PIWI-interacting RNAs (piRNAs) are small non-coding RNAs that are very abundant in animal 
gonads. They were named because of their ability to associate with Argonaute proteins of the 
PIWI subfamily [1-4]. piRNAs share common biochemical features, including the 
phosphorylation of the 5’end and the 2’ O-methylation of the 3’end. Mature piRNAs are 
processed through a maturation pathway involving the cleavage by PIWI proteins of long single-
stranded RNAs transcribed from ‘piRNA clusters’ present in both intra- and inter-genic regions 
of the genome [5, 6].  
piRNAs are believed to maintain genome integrity by guiding PIWI proteins to repress 
transposon activity, to regulate the assembly of the telomere protection complex and to be 
involved in RNA silencing and in the epigenetic control of gene expression [5, 7-9]. Until 
recently, the piRNA pathway was perceived as germline-specific but piRNAs have also been 
detected in stem cells and other cell types, suggesting that these small non-coding RNAs may 
accomplish additional tasks [10-12]. Despite the poorly understood role of piRNAs in somatic 
cells, there is rising evidence indicating that these non-coding RNAs control gene expression by 
acting at genomic but also at transcriptional and post-transcriptional levels [13-17]. Indeed, 
recent studies have highlighted the involvement of the PIWI-piRNA pathway in both 
physiological and pathological processes, including development [18], memory [19], liver 
regeneration [20] and cancer [21-26]. However, nothing is known about their role in metabolic 
disease such as diabetes.  
Pancreatic islets play key roles in the regulation of metabolism and energy homeostasis by 
secreting hormones in response to changes in the nutritional status. Pancreatic beta-cell 
dysfunction and loss are critical determinants for type 2 diabetes development. There is strong 
evidence indicating that altered expression of both protein-coding and non-coding genes is 
associated with beta-cell dysfunction under prediabetes and diabetes conditions [27]. Several 
studies have implicated miRNAs and lncRNAs as key players in diabetes [28-30].  So far, no 
information is available about the presence of PIWI-piRNAs complexes in beta-cells and their 
possible involvement in islet physiology and in diabetes development. The goal of this study was 
to analyze the piRNA expression patterns of rat pancreatic islets under both physiologic and 
pathological conditions and to assess their contribution to the maintenance of beta-cell function. 
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METHODS 
Animals  
Male Sprague-Dawley and Wistar rats and pregnant Sprague-Dawley rats, were obtained from 
Janvier Laboratories (Le Genest-Saint-Isle, France) and were housed on a 12-hour light, 12-hour 
dark cycle in climate-controlled and pathogen-free facilities. The detailed sources of Goto-
Kakizaki rats have been described previously [31]. All animal procedures were performed in 
accordance with the National Institutes of Health guidelines and were approved by the Swiss 
Research Councils and Veterinary Offices or by the local ethics committee in Malmö. 
Islet isolation, organ collection and cell culture 
Rat pancreatic islets were isolated by collagenase digestion (Roche, ), followed by purification on 
a Histopaque density gradient (Sigma-Aldrich, St Louis, MO, USA) [32] and final cleaning by 
hand-picking. The islets were cultured in RPMI1640 Glutamax medium (Invitrogen, Carlsbad, 
CA, USA), supplemented with 10% FCS (Gibco), 100 μg/mL streptomycin, 100 IU/mL 
penicillin , 1 mmol/l sodium pyruvate and 10 mmol/l HEPES, pH 7.4. Human islets obtained 
from the Cell Isolation and Transplantation Center (University of Geneva, Switzerland) were 
cultured in CMRL1066 medium (Invitrogen) supplemented with 10% FCS, 100 μg/mL 
streptomycin, 100 IU/ml penicillin, 2 mmol/l L-glutamine, and 250 μmol/l HEPES. The use of 
human islets was approved by the Geneva local ethical committee. Dissociated islet cells were 
obtained by digestion with 5 mg/ml of trypsin (Gibco). Adipose tissue, brain, liver and skeletal 
muscle were collected from Wistar rats aged of 12 weeks.  
Fluorescence Activated Cell Sorting of islet cells 
Dissociated islet cells from newborn and adult rats were sorted by Fluorescence Activated Cell 
Sorting (FACS) based on beta-cell autofluorescence [33]. Immunocytochemistry analysis using 
anti-insulin antibodies (Dako: #A0564) revealed that 94±1% of the cells in the purified fraction 
were insulin-positive. 
Cell transfection 
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Dissociated islet cells were transfected with pre-designed siRNAs (Life technologies), using as 
control a siRNA directed against GFP (Eurogentec, Seraing, Belgium). Synthetic RNA 
oligonucleotides with a 5’ phosphorylation and 3’ 2-O-methylation (Integrated DNA 
technologies) were used as piRNA mimics. Transfection was carried out using Lipofectamine 
RNAiMax (Invitrogen). To overexpress the piRNAs we used following sequences: (DQ732700): 
5’UAUGAAGAAUGACUUGGGGUACAUGACC-3’; (DQ746748): 5’-
ACUGGAAACGGAAAACUCAGAGCGCCC-3’. Control oligonucleotide: 5’-
GUGUAACACGUCUAUACGCCCA-3’. Functional assays were performed 48h after 
transfection. 
Insulin secretion 
Islet cells were preincubated in KREBS buffer containing 25mM HEPES, pH 7.4, 0.1% BSA 
(Sigma-Aldrich) and 2 mmol/l glucose for 30 minutes at 37°C. The medium was then replaced by 
KREBS buffer containing 0.1% BSA supplemented with 2 mmol/l glucose, 20 mmol/l glucose or 
2 mmol/l glucose and 35mmol/l KCl. After 45 min, the supernatants were collected and 
centrifuged at 1200xg for 5min to remove cell debris. Total cellular insulin contents were 
recovered in EtOH acid (75% EtOH, 0.55% HCl) and protein contents were collected on ice in a 
lysis buffer containing 50 mmol/l Tris-HCl, pH 7.5, 5 mM EDTA, 0.5 % Triton-X-100 and 
protease inhibitors (Roche, Rotkreuz, Switzerland). The amount of insulin in the samples was 
determined by ELISA (Mercodia, Uppsala, Sweden). Protein content was evaluated using the 
Bradford protein Assay (Bio-Rad, Reinach, Switzerland).  
Proliferation assay 
Dissociated islet cells were cultured on poly-L-lysine–coated glass coverslips and treated, or not, 
for 48h with 500ng/ml Prolactin (Sigma-Aldrich) to stimulate proliferation. The cells were fixed 
in 4% PFA and incubated with PBS supplemented with 0.5% saponin (Sigma-Aldrich) for 20 
min. The coverslips were incubated for 30 min in PBS supplemented with 0.5% saponin and 1% 
BSA and exposed for 1h to the following antibodies: 1:1’500 rabbit anti-Ki67 (Abcam, 
Cambridge, UK); 1:100 guinea pig anti-insulin (Millipore, Zug, Switzerland). They were then 
washed and incubated for 1h with goat anti-rabbit Alexa Fluor 488 or goat anti–guinea pig Alexa 
Fluor 594 diluted at 1:400 (Invitrogen). Finally, the coverslips were incubated for 10 min with 
8 
 
Hoechst 33342 (Invitrogen) and mounted on microscope glass slides. The cells were visualized 
with a Zeiss Axiovision fluorescence microscope. At least 600 cells were analyzed for each 
condition. The total number of cells was assessed using the ImageJ software, while Ki67-positive 
cells were counted manually.  
Cell death assessment 
Cell death was triggered by exposing the cells to pro-inflammatory cytokines (30 ng/ml IFNγ, 10 
ng/ml TNFα and 0.1 ng/ml IL-1β) for 24 h. The cells were incubated for 5 min at 37°C with 
Hoechst 33342 (Invitrogen). About 400 cells per condition were analyzed by fluorescence 
microscopy (Axiovert 25; Zeiss, Feldbach, Switzerland) to score the fraction of them displaying 
pycnotic nuclei.  
RNA extraction and measurement 
Total RNA from islets or from other rat organs was extracted using the miRNeasy kit (Qiagen, 
Basel, Switzerland). For microarray analysis and qRT-PCR, pancreatic islets from two to five 
P10 pups (without sex distinction) were pooled while islets from adult male rats were extracted 
individually. piRNA levels were measured using specific custom primers and the miScript Plant 
RT kit (Qiagen). Measurement of mRNAs levels was performed by qPCR (Bio-Rad, Sso 
Advanced Universal SYBR Green Supermix) using custom primers (Microsynth, Balgach, 
Switzerland) (see [ESM] Methods). All PCR products where validated by sequencing 
(Microsynth). piRNA expression was normalised to U6, while mRNA expression was normalised 
to α-tubulin mRNA using the ΔCt method. 
piRNA profiling  
Global piRNA profiling was carried out using a Rat piRNA Array (Arraystar, Rockville MD). 
Rat piRNA sequences from the NCBI database were mapped to the RN4 genome using UCSC 
Blat. Probes for about 40’000 piRNAs were spotted on an Agilent array platform. Samples were 
labeled using a RNA ligase method and were hybridized onto the piRNA Array in Agilent’s 
SureHyb Hybridization Chambers. Quantile normalization and data processing were performed 
using the GeneSpring GX v11.5.1 software (Agilent Technologies, Santa Clara, CA, USA). 
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Differentially expressed piRNAs with statistical significance between the two groups were 
identified through Volcano Plot filtering. Hierarchical Clustering was performed to show the 
distinguishable piRNA expression pattern among samples.  
Prediction of piRNA target genes 
The putative binding sites of DQ732700 and DQ746748 present in the 3'UTR sequences of all 
the genes expressed in rat islets [34] were identified with the PITA algorithm using default 
parameters [35]. For each piRNA, the top 300 putative targets based on the PITA score were 
annotated with their gene ontology (GO) using biomaRt [36]. Pathway enrichment analysis was 
performed using DAVID with KEGG and Reactome pathway annotations. 
Statistical analysis 
Statistical differences were tested using Student’s t test or, for multiple comparisons, one-way 
ANOVA followed by a post hoc Dunnett’s test, with a discriminating p-value of 0.05 ( GraphPad 
Software, San Diego, CA).  Differences in piRNAs expression between purified beta-cells of p10 
and adult rats were assessed using 1-sample t-test, with a discriminating p-value of 0.05 using 
Statistical Package for Social Sciences (IBM SPSS version 23). 
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RESULTS 
The PIWI/piRNA pathway is active in rat pancreatic islets 
There is mounting evidence suggesting that, in addition to their well-established role in germinal 
cells, piRNAs may contribute also to the regulation of somatic cell activities [11]. To investigate 
the potential involvement of piRNAs in the control of pancreatic beta-cell functions, we first 
assessed whether insulin-secreting cells express some of the key components of the piRNA 
pathway. Although to a much lower level compared to rat testis (Fig.1a), qRT-PCR analysis 
revealed the expression in rat pancreatic islets of the PIWI-like genes Piwil2 and Piwil4 but not 
Piwil1 (Fig.1b). The expression of these two PIWI-like genes was confirmed in FACS-sorted 
beta-cells from adult (three-month old) (Fig.1c) and newborn (10-days old) rats (ESM Fig.1). 
Similar findings were also obtained with human pancreatic islets that were found to express the 
human orthologues of these PIWI genes, Hili and Hiwi2 (Fig.1d). The expression of PIWI-like 
genes in islets was comparable to the level measured in other somatic tissues such as the adipose 
tissue, brain, liver and skeletal muscle (ESM Fig.1). Beside Piwil2 and Piwil4, qRT-PCR analysis 
unveiled also the presence in rat pancreatic islets of the mRNAs of several other genes involved 
in piRNA biogenesis [5, 6, 37], including Henmt1, Mael, Ddx4, Pld6 and Prmt5 which are main 
players in the pathway as well as some of the TUDOR domain-containing genes [38] Tdrd1, 
Tdrd2 and Tdrd6 (Fig.1e,f).  
 The presence of several components of the piRNA pathway prompted us to assess 
whether pancreatic islets express a specific pool of piRNAs. Indeed, analysis of islet RNA 
isolated from adult and newborn rats using a dedicated microarray, permitted to detect the 
presence of 18’540 of the 40’000 tested piRNAs (GSE93790). Hierarchical clustering 
summarizes the top differentially regulated piRNAs (Fig.2a). 
We then assessed whether islet piRNA expression is modulated in response to 
physiological or pathological conditions. Newborn beta-cells display major functional differences 
compared to fully mature beta-cells. In fact, neonatal beta-cells show a much higher proliferation 
rate compared to adult beta-cells [34]. Moreover, newborn beta-cells are unable to secrete insulin 
in response to glucose and acquire this property only after undergoing a postnatal maturation 
process that involves a major rearrangement in the gene expression profile [34]. We observed that 
the functional maturation of beta-cells is associated with changes in the level of numerous 
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piRNAs. Indeed, by comparing the levels in newborn (10-days old) and adult (three-month old) 
rat islets by microarray, we found that the expression of 735 piRNAs is reduced, while that of 
1056 piRNAs is increased upon functional beta-cell maturation (nominal p-value ≤ 0.05, fold 
change ≥ 2) (GSE93790). The observed changes in the level of selected piRNAs were confirmed 
by qRT-PCR in whole islets (Fig.2B) and in highly purified beta-cell fractions (Fig.2c). These 
findings suggest that piRNAs may possibly contribute to the functional maturation of beta-cells. 
We next assessed whether altered piRNA expression can contribute to beta-cell 
dysfunction observed under diabetic conditions. For this purpose, we compared the piRNA 
expression profile of the islets of Wistar and Goto-Kakizaki (GK) rats, a well-established model 
of non-obese Type 2 diabetes characterized by impaired glucose-stimulated insulin secretion [31, 
39]. By microarray, we identified 347 piRNAs differentially expressed (p-value ≤ 0.05, fold 
change ≥ 2) in the islets of diabetic GK rats (128 up-regulated and 219 down-regulated) 
(GSE93791). Hierarchical clustering summarizes the top differentially regulated piRNAs 
(Fig.3a). The changes in the level of three of these piRNAs was confirmed by qRT-PCR (Fig.3b). 
Thus, our results indicate that the piRNA expression profile is modified under diabetic 
conditions, potentially contributing to the development of the disease. 
 
PIWI/piRNAs impact on beta-cell functions 
We next investigated whether global changes in piRNA activity impact on beta-cell functions. 
For this purpose, we used RNA interference to silence Piwil2 and Piwil4 genes in pancreatic islet 
cells. siPiwil2 and siPiwil4 reduced the expression of their target mRNAs by about 80 and 50%, 
respectively (Fig.4a-b). Silencing of Piwil2 and Piwil4 genes resulted in a reduction in the level 
of several piRNAs (Fig.4c). To investigate if the impaired piRNA expression affects the activities 
of beta-cells, we measured insulin secretion in response to glucose or to depolarizing KCl 
concentrations upon silencing of Piwil2 or Piwil4 in islet cells. We found that knockdown of 
Piwil2 or Piwil4 does not affect insulin content (Fig.5a,c). However, in the absence of Piwil2 or 
Piwil4, both glucose- and KCl-induced insulin secretion were significantly decreased (Fig.5b,d), 
suggesting a functional impairment in the secretory machinery that could also involve a defect in 
glucose metabolism. We then tested cell survival and proliferation. This revealed that upon 
silencing of Piwil2 or Piwil4, beta-cells become more resistant to cytokine-induced cell death 
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(Fig.5e). In contrast, beta-cell proliferation both in the presence or absence of the mitogenic 
hormone prolactin was not significantly affected (Fig.5f).  
 The observed changes in the expression of piRNAs occurring during the acquisition of the 
mature beta-cell phenotype and in diabetic conditions, suggest that deregulation of specific 
piRNAs may potentially contribute to beta-cell dysfunction under disease states. To test this 
hypothesis, we overexpressed DQ732700 and DQ746748 piRNAs in islet cells of normoglycemic 
Wistar rats, in order to mimic the increase observed in the islets of diabetic GK rats, and assessed 
the impact on insulin secretion. We found that overexpression of DQ732700 or DQ746748 does 
not affect cellular insulin content (Fig.6a,c). However, the increase in the level of these two 
piRNAs resulted in a decrease in insulin release in the presence of elevated glucose 
concentrations (Fig.6b). In contrast, insulin secretion in response to depolarizing concentrations 
of KCl was not affected (Fig.6d). Since Type 2 diabetes is in some cases associated with beta-cell 
apoptosis, we also assessed whether the overexpression of these two piRNAs affects the survival 
of the insulin-secreting cells. As shown in Fig.6e, the increase of these two piRNAs did not 
modify the survival of the cells both in the presence or absence of a mix of pro-inflammatory 
cytokines including IL-1β, TNFα and IFNγ.   
piRNAs have been proposed to exert a translational repression through mechanisms 
similar to those of miRNAs [14]. Thus, we used a computational approach to search for the 
potential targets of DQ732700 and DQ746748. Interestingly, the putative targets of these piRNAs 
were significantly enriched for genes involved in insulin secretion and insulin action (GSE93792; 
ESM Tables 1-2). 
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DISCUSSION 
Type 2 diabetes is characterized by a diminished sensitivity of insulin target tissues and defective 
insulin secretion from beta-cells. The mechanisms underlying these phenomena are not fully 
understood, but appear to involve alterations in the expression of mRNAs and non-coding RNAs 
[28-30]. piRNAs constitute an abundant class of non-coding RNAs and contribute to genome 
stability. In germ cells, they interact with PIWI proteins during early embryogenesis enabling the 
silencing of transposable elements in the genome [5]. In addition to their well-established role in 
the germline, there is emerging evidence for an involvement of these small RNAs in the 
regulation of gene expression in somatic cells [10-12, 40]. However, the presence of piRNAs in 
beta-cells and their possible contribution to the regulation of gene expression have so far not been 
explored. In this study, we used a microarray approach to obtain a comprehensive picture of the 
piRNAs expressed in rat pancreatic islets and to evaluate the modifications taking place during 
the acquisition of a fully mature beta-cell phenotype. This led to the identification of a large 
number of piRNAs, many of which display changes in their level occurring in association with 
the functional maturation of beta-cells. These findings suggest that piRNAs may potentially 
contribute to the development of pancreatic beta-cells. Additional studies will be needed to 
delineate the precise role of piRNAs in the acquisition of specific properties of beta-cells, such as 
the capacity to secrete insulin in response to glucose. 
PIWI proteins are essential for the biogenesis and the activity of piRNAs and have been 
suggested to be involved in the transcriptional, post-transcriptional and epigenetic regulation of 
gene expression [13-17, 40, 41]. We found that rat and human pancreatic islet cells express two 
PIWI genes. These observations were confirmed in highly purified beta-cell fractions, rendering 
unlikely the possibility that the expression of these genes is confined exclusively in other cells 
present in the islets. Interestingly, down-regulation of Piwil2 and Piwil4 mRNAs in rat islets 
resulted in a significant decrease in insulin secretion upon glucose or KCl stimulation, suggesting 
that the activity of these PIWI proteins is important to preserve the secretory capacity of beta-
cells. The silencing of Piwil2 and Piwil4 was associated with a decrease in the level of several 
piRNAs, suggesting that the effect may be linked to changes in the biogenesis, the stability and/or 
the activity of these small non-coding RNAs.  
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The involvement of piRNAs in pathological processes is starting to emerge. Indeed, the 
levels of some of these small RNAs have been associated with different clinical conditions and 
have been proposed as prognostic markers for different types of cancer [42]. However, the 
understanding of the contribution of these non-coding RNAs to diseases is still rudimentary and 
necessitates further exploration. Piwil mRNA levels have been reported to be deregulated in 
cancerous tissues and to be correlated with clinico-pathological features of the tumors [43-45]. In 
certain human cancers, Piwil2 has been reported to affect the survival of the cells by interacting 
with signal transducer and activator of transcription 3 and by regulating the p53 signaling 
pathway [46]. Moreover, Piwil4 was shown to promote cell proliferation and to inhibit apoptosis 
in human cervical cancer tissues by down-regulating the p14ARF/p53 pathway [47]. A decrease 
in the level of these Piwil genes was also found to be associated with tumor progression and with 
a reduced survival of renal carcinoma patients [43]. Thus, the role of Piwil genes may vary 
according to the cellular context. In our study, we observed that down-regulation of Piwil2 and 
Piwil4 mRNAs in beta-cells has a protective effect against cytokine-induced cell death and has 
no significant impact on proliferation. Further investigations will be needed to precisely delineate 
the signaling pathways through which Piwil2 and Piwil4 affect the survival of beta-cells.   
In this study, we identified several piRNAs that are differentially expressed in the islets of 
diabetic GK rats, a Wistar substrain obtained by selective breeding of a colony displaying high 
blood glucose levels. The genetic determinants responsible for the development of diabetes in 
GK rats are not yet fully established. Thus, the observed changes in piRNA expression may be 
due either to genetic differences between the GK and Wistar substrains or be the consequence of 
chronic hyperglycemia. To investigate the potential role of these piRNAs in beta-cell dysfunction 
and in Type 2 diabetes development, we selected two piRNAs that are up-regulated in the islets 
of GK rats and we overexpressed them in the islets of control Wistar rats. Interestingly, this 
resulted in a selective defect in glucose-induced insulin secretion, providing initial evidence for a 
contribution of piRNA deregulation in the diabetic phenotype of GK rats. The overexpression of 
these two piRNAs did not affect cell survival, indicating that the defect in insulin secretion does 
not result from a toxic effect of these small RNAs. The mechanism through which DQ732700 
and DQ746748 affect insulin secretion remains to be determined. Since KCl-induced insulin 
secretion is not impaired, the overexpression of these two piRNAs is unlikely to perturb the 
expression of general components of the exocytotic machinery.  
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Our findings would rather suggest that the overexpression of DQ732700 and DQ746748 
interferes with the generation of metabolic factors coupling glucose sensing to insulin release. 
Alternatively the piRNAs may affect granular recruitment, a process that is dependent on 
metabolic factors [48, 49]. piRNAs have been suggested to control gene expression via 
mechanisms analogous to those of microRNAs [14]. Computational prediction of the potential 
targets of these two piRNAs highlighted an enrichment in genes involved in insulin secretion, 
insulin action or carbohydrate digestion. Future studies will have to experimentally validate these 
targets and to assess whether their silencing can indeed contribute to the effect of the piRNAs.  
The unexpected discovery of the existence of thousands of non-coding transcripts with 
regulatory properties opens new perspectives in the understanding of the mechanisms that govern 
the activities of mammalian cells. Our data provide initial evidence for an involvement of 
piRNAs in the control of beta-cell functions under both physiological and pathological 
conditions. These findings add an additional layer of control to the regulation of gene expression 
in insulin-secreting cells. A better understanding of the role and the mode of action of piRNAs in 
beta-cells will help elucidate the molecular events driving the acquisition of a mature beta-cell 
phenotype and the causes of beta-cell dysfunction in diabetes conditions. This knowledge will be 
instrumental for the engineering of beta-cell surrogates for the replacement of insulin-secreting 
cells and to promote the development of new therapeutic strategies for the treatment of Type 2 
diabetes.  
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FIGURE LEGENDS 
 
Fig.1) Pancreatic islets express several components of the Piwil-piRNA pathway  
qRT-PCR measurement of the level of Piwil mRNAs in rat testis (a) rat pancreatic islets (b) 
FACS-sorted rat beta-cells (c) and human islets (d). qRT-PCR analysis of the mRNAs of selected 
components of the Piwil-piRNA pathway in and rat testis (e) and rat islets (f). The results are 
means ± SD, n=3-4. ND: Not Detected. 
 
Fig.2) Changes in the level of piRNAs during beta-cell maturation  
A) Hierarchical clustering of 236 piRNAs differentially regulated (p-value<0.05, absolute fold 
change > 2, normalised expression > 6) between pancreatic islets of adult and newborn rats. 
Yellow tones highlight piRNAs displaying an up-regulation and blue tones a downregulation 
compared to the other group. Dark tones represent no significant change. The level of the 
indicated piRNAs in the whole islets (b) and purified beta-cells (c) of newborn (black bars) and 
adult rats (white bars) was analyzed by qRT-PCR. The data are means ± SD of the ΔCt values. 
Statistical differences were assessed by Student’s t test *= p ≤ 0.05, ** = p≤0.01, n=3.  
 
Fig.3) Changes in piRNA expression in a type 2 diabetes model 
a) Hierarchical clustering of 99 piRNAs (p-value<0.05, absolute fold change> 2, normalised 
expression > 6) differentially expressed between GK and Wistar rat islets. Dark tones represent 
no significant change, yellow tones an up-regulation and blue tones a downregulation. b)  The 
expression of the three indicated piRNAs in the islets of GK (white bars) and Wistar rats (black 
bars) was measured by qRT-PCR. The data are means ± SD of the ΔCt values. Statistical 
differences were assessed by Student’s t test *= p ≤ 0.05, n=3.  
 
Fig.4) Down-regulation of Piwil2 and Piwil4 expression in rat islet cells using siRNAs 
a, b, c) The expression of the indicated mRNAs and piRNAs was measured by qRT-PCR. a, b) 
Dissociated rat islet cells were transfected with a control siRNA or with siRNAs directed against 
Piwil2 (a) or Piwil4 (b). The expression of the indicated mRNAs was measured 48h after 
transfection by qRT-PCR. c) The level of the indicated piRNAs was measured by qRT-PCR, 48h 
after transfection with a control siRNA (black bars), siPiwil2 (white bars) or siPiwil4 (grey bars). 
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Results are presented as means ± SD. Statistical differences were assessed by Student’s t test 
versus control, * = p≤0.05, ** = p≤0.01, n=3-5. 
 
Fig.5) Functional impact of Piwil2 and Piwil4 silencing  
Dissociated rat islet cells were transfected with a control siRNA or with siRNAs directed against 
Piwil2 or Piwil4. The secretory properties of the cells were assessed 48h later. a) Insulin content 
and b) insulin secretion in the presence of 2 mmol/l (black bars) or 20 mmol/l glucose (white 
bars) were measured by ELISA. c) Insulin content and c) insulin secretion at 2mmol/l glucose in 
the absence (black bars) or in the presence of 35 mmol/l KCl (grey bars). e) Adult rat islet cells 
were transfected with the indicated siRNAs. One day later, the cells were incubated in the 
presence (white bars) or in the absence (black bars) of proinflammatory cytokines (IL-1β, TNFα 
and IFNγ). Cell death was assessed 24h later by counting the number of cells displaying pyknotic 
nuclei. f) Proliferation of beta-cells transfected with the indicated siRNAs was assessed by 
counting the fraction of cells positive for insulin and Ki67 in the presence (white bars) or absence 
(black bars) of 500ng/ml prolactin. Results are means ± SD. Statistical differences were assessed 
by One-Way ANOVA test, * = p≤ 0.05, ** = p≤0.01, n=4-5. 
 
Fig.6) Effect of the overexpression of DQ732700 and DQ746748 piRNAs  
Dissociated rat islet cells were transfected with a control oligonucleotide or with oligonucleotides 
mimicking the sequence of DQ732700 or DQ746748 piRNAs. Two days later, the cells were 
incubated for 45 min with 2 mmol/l glucose, 20 mmol/l glucose or 35 mmol/l KCl. a) Insulin 
contents and b) insulin secretion at 2 mmol/l (black bars) and 20 mmol/l glucose (white bars). c) 
Insulin contents and d) insulin secretion at 2mmol/l glucose in the absence (black bars) or in the 
presence of 35 mmol/l KCl (grey bars). e) Rat islet cells were transfected with the indicated 
piRNAs. The day after, the cells were incubated in the presence (white bars) or in the absence 
(black bars) of IL-1β, TNFα and IFNγ. Cell death was assessed 24h later by counting the number 
of cells displaying pyknotic nuclei. Results are means ± SD. Statistical differences were assessed 
by One-Way ANOVA test, * = p≤0.05, ** = p≤0.01, n=5-6. 
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Sequence of the primers used for qRT-PCR 
Gene name Forward primer : 5` → 3` Reverse primer : 5` → 3` 
Piwil2 CATTGTCATCACACGCTACAAC CTCCTTCCCATCCGACATTAC 
Piwil4 GCGGTTGCTATGCTTTGTTC ACCCTCTCCTTCCCAATACTTA 
HENmt1 AAAACGGTGGGAAGCTCTCT TCTCCTGCTGTAAACTCGGG 
ASZ1 GTACTGGAGTGGGCTTCACC TCCCGTTCATTCTGCATCTTCT 
Ddx4 GATGCACCACCGGCAATTTT ACTTCTGCACAGGAGTGAGC 
Mael GGCATGACCAAGCAACTGTG GCCTTATTTCTGATGCCCGC 
Pld6 CGCAAGGCAGGTATACAGGT TGTGGTCCAATTGAGGGAGC 
Prmt5 TTCTTCCCCATCAAGCAGCC GCGACCAGTAGGGTTGTGAA 
Tdrd1 TGGAACCGAGCCGTAGTAGA TTATGGCGGAAGGGGGAAAC 
Tdrd2 TCCTGTTCAGGTGTGCAAGG TCACCGCCTCTCCCTATGAT 
Tdrd6 GGCACACGACGAAATGAACC TCAACTGCTGGTACTTCGCT 
Hiwi/Piwil1 GACTCCGTTCAGCTCTTCTTT TCTCCATTCCGGGTCTTACT 
Hili/Piwil2 TGGGTTTGGTCTCCATGTTC CTGTCCTTGCGTACCAGATTAG 
Hiwi2/Piwil4 TCAGCCCATGCTTGTTAGTC GTCAGTCAGCCCTGTTAGAAAG 
 
ESM Table 1
Pathway analysis of the targets of DQ732700 predicted with the PITA algorithm using default parameters [35]. The top 300 putative targets based on the PITA score were annotated 
with their gene ontology using biomaRt [36]. Pathway enrichment analysis was performed using DAVID with KEGG and Reactome pathway annotations.
Category Term Count p-Value Genes Fold Enrichment
KEGG_PATHWAY rno04964:Proximal tubule bicarbonate reclamation 4 0.0043 ATP1B3, GLUD1, ATP1A2, AQP1 11.79
REACTOME_PATHWAY R-RNO-2028269:Signaling by Hippo 4 0.0052 YWHAB, AMOTL2, STK4, LATS2 11.06
KEGG_PATHWAY rno04931:Insulin resistance 7 0.0066 CRTC2, MLX, PPP1R3A, OGT, IRS1, AKT2, PTPN11 4.13
KEGG_PATHWAY rno04911:Insulin secretion 6 0.0100 ATP1B3, CAMK2D, VAMP2, ATP1A2, PCLO, CACNA1D 4.52
REACTOME_PATHWAY R-RNO-5578775: Ion homeostasis 5 0.0147 ATP2B2, ATP1B3, CAMK2D, AHCYL1, ATP1A2 5.217
KEGG_PATHWAY rno04022:cGMP-PKG signaling pathway 8 0.0152
ATP2B2, ATP1B3, GATA4, GUCY1B3, ATP1A2, IRS1, 
CACNA1D, AKT2
3.05
KEGG_PATHWAY rno05031:Amphetamine addiction 5 0.0163 DDC, ARC, MAOB, CAMK2D, CACNA1D 5.07
KEGG_PATHWAY rno05206:MicroRNAs in cancer 7 0.0221 WNT3, SLC7A1, ERBB2, SOS2, RDX, IRS1, DDIT4 3.17
KEGG_PATHWAY rno04261:Adrenergic signaling in cardiomyocytes 7 0.0242
ATP2B2, ATP1B3, CAMK2D, CACNB2, ATP1A2, 
CACNA1D, AKT2
3.11
KEGG_PATHWAY rno04973:Carbohydrate digestion and absorption 4 0.0244 ATP1B3, ATP1A2, CACNA1D, AKT2 6.33
KEGG_PATHWAY rno04920:Adipocytokine signaling pathway 5 0.0275 TNFRSF1B, ACSL1, IRS1, AKT2, PTPN11 4.32
KEGG_PATHWAY rno04970:Salivary secretion 5 0.0287 ATP2B2, ATP1B3, GUCY1B3, VAMP2, ATP1A2 4.27
ESM Table 2
Pathway analysis of the targets of DQ746748 predicted with the PITA algorithm using default parameters [35]. The top 300 putative targets based on the PITA score were
annotated with their gene ontology using biomaRt [36]. Pathway enrichment analysis was performed using DAVID with KEGG and Reactome pathway annotations.
Category Term Count p-Value Genes Fold Enrichment
KEGG_PATHWAY rno04910:Insulin signaling pathway 9 6.55E-04
PPP1R3D, CRKL, SOCS4, PPP1R3A, PPP1CB, 
CRK, LIPE, G6PC3, PYGB
4.63
KEGG_PATHWAY rno04931:Insulin resistance 8 7.61E-04
PPP1R3D, GFPT2, PPP1R3A, PPP1CB, 
G6PC3, CPT1A, PYGB, PTPN11
5.24
KEGG_PATHWAY rno04152:AMPK signaling pathway 7 0.0079
MAP3K7, AKT1S1, ADIPOR2, ADIPOR1, 
LIPE, G6PC3, CPT1A
3.97
KEGG_PATHWAY rno04920:Adipocytokine signaling pathway 5 0.0195
ADIPOR2, ADIPOR1, G6PC3, CPT1A, 
PTPN11
4.80
KEGG_PATHWAY rno04270:Vascular smooth muscle contraction 6 0.0261
EDNRA, RAMP3, MRVI1, PRKCH, PLA2G2D, 
PPP1CB
3.54
REACTOME_PATHWAY R-RNO-170968: Frs2-mediated activation 3 0.0262 CRKL, FRS2, CRK 11.66
REACTOME_PATHWAY
R-RNO-163560: Hormone-sensitive lipase (HSL)-
mediated triacylglycerol hydrolysis
3 0.0292 FABP7, PPP1CB, LIPE 11.01
KEGG_PATHWAY rno01130:Biosynthesis of antibiotics 8 0.0309
TPI1, BCAT2, HMGCS2, GFPT2, GGPS1, 
AASS, TKT, PAPSS2
2.63
ESM Fig.1
qRT-PCR measurement of the level of Piwil2 and Piwil4 mRNAs in rat tissues and
purified beta-cells. Adipose tissue, brain, liver and skeletal muscle were collected from
Wistar rats aged of 12 weeks. Highly enriched fractions of adult (3 month-old) and newborn
(10 days-old) rats containing about 95% of insulin-positive cells were obtained by FACS-
sorting. The results are means ± SD of the ΔCt values, n=3. Newborn beta-cells represent a
pool of 5 pups.
